19712-89-1

Basic information

• Product Name: Benzeneacetic acid, 4-(phenylmethoxy)-, 1,1-dimethylethyl ester
• CAS NO: 19712-89-1
• Molecular Formula: C19H22O3
• Molecular Weight: 298.382
• Mol File: 19712-89-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzeneacetic acid, 4-(phenylmethoxy)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzeneacetic acid, 4-(phenylmethoxy)-, 1,1-dimethylethyl ester(19712-89-1)
• EPA Substance Registry System: Benzeneacetic acid, 4-(phenylmethoxy)-, 1,1-dimethylethyl ester(19712-89-1)

Safety Data

• Hazardous Substances Data: 19712-89-1(Hazardous Substances Data)

Upstream product

• 6793-92-6 p-benzyloxyphenylbromide 
• 51656-70-3 (2-tert-butoxy-2-oxoethyl)zinc(II) bromide 
• 6547-53-1 2-[4-(benzyloxy)benzyl]acetic acid 
• 115-11-7 isobutene 
• 93796-44-2 2-(3,4-dibenzyloxyphenyl)-2-methoxycarbonyl-1,3-dithiane 
• 5447-02-9 3,4-dibenzyloxybenzaldehyde 
• 75-65-0 tert-butyl alcohol 
• 93796-46-4 (E)-5'-<α-methoxycarbonyl-(3,4-dibenzyloxybenzylidene)>cyclohexanespiro-2'-(1',3'-dioxolan)-4'-one 
• 93796-45-3 methyl 3,4-dibenzyloxyphenylglyoxylate 
• 58594-01-7 2-(3,4-bis(benzyloxy)phenyl)-1,3-dithiane 

Downstream Products

• 16010-88-1 tert-butyl 2-(4-hydroxyphenyl)acetate 
• 16010-89-2 3-<4-Carboxy-methyl-phenoxy>-4-methoxy-phenylessigsaeure-methylester 

Relevant articles and documents

Photoinduced Palladium-Catalyzed Negishi Cross-Couplings Enabled by the Visible-Light Absorption of Palladium–Zinc Complexes

A visible-light-induced Negishi cross-coupling is enabled by the activation of a Pd0–Zn complex. With this photocatalytic method, the scope of deactivated aryl halides that can be employed in the Negishi coupling was significantly expanded. NMR experiments conducted in the presence and absence of light confirmed that the formation of the palladium–zinc complex is key for accelerating the oxidative addition step.

AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS

The present invention relates to a compound formula [I] or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

Studies on the alkaloids of menispermaceous plants. CCXLIV. Synthesis of dl-cepharanthine.

-